Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-pegylated liposomal doxorubicin (TLC D-99) plus ifosfamide in metastatic soft tissue sarcoma
2008-003316-36Phase 2Completed
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Aug 2008
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vincristine sulfate liposome and ifosfamide in soft tissue sarcoma (STS), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoints: Global response rate and Clinical benefit. Started Aug 2008; status: completed.
02
Drugs
vincristine sulfate liposomeifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2008-003316-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003316-36.